Skip to main content
Europlasma logo

Europlasma — Investor Relations & Filings

Ticker · ALEUP ISIN · FR001400CF13 LEI · 969500WYVNHBV1ABQ250 Euronext Growth Water supply; sewerage, waste management and remediation activities
Open in API
Filings indexed 506 across all filing types
Latest filing 2022-03-03 Declaration of Voting R…
Country FR France
Listing Euronext Growth ALEUP

About Europlasma

https://www.europlasma.com/en/

Europlasma is a company specializing in clean technology and energy solutions. Its core activities focus on the research, engineering, and application of plasma solutions for industrial purposes, particularly for the treatment of hazardous waste and gas. The company provides services for the destruction and valorization of asbestos waste. In the decarbonization sector, Europlasma transforms waste into Solid Recovered Fuel (SRF). Additionally, the company operates an industrial division that manufactures hollow bodies and anodized sheets for capacitors.

Recent filings

Filing Released Lang Actions
EUROPLASMA: Information relative au nombre total de droits de vote et d'actions composant le capital au 28 février 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release dated March 3, 2022, titled "Information relative au nombre total de droits de vote et d'actions composant le capital au 28 février 2022" (Information relative to the total number of voting rights and shares comprising the capital as of February 28, 2022). It explicitly states the total number of shares and voting rights, referencing French commercial code (L. 233-8 II) and AMF regulations (223-16). This type of periodic disclosure regarding the total number of shares and voting rights is a standard regulatory requirement, often related to capital structure changes or general compliance. While it is a regulatory announcement, it specifically deals with the composition of the capital and voting rights, which is a specific type of disclosure. It is not a general earnings release (ER), a major shareholding notification (MRQ, which focuses on ownership changes crossing thresholds), or a capital change announcement (CAP, which usually involves fundraising or issuance). Given the options, this specific disclosure about the total number of shares and voting rights most closely aligns with a general regulatory filing or a specific capital structure update. Since it is a mandatory, periodic disclosure of the capital structure's components, and not a major financing event (CAP) or a change in major ownership (MRQ), it fits best under the general regulatory announcement category (RNS) or potentially a specific capital/financing update (CAP) if the context implies a change. However, the core content is the official count of shares/votes, which is a routine regulatory disclosure. Given the available codes, RNS (Regulatory Filings) is the most appropriate fallback for mandatory, non-specific regulatory updates, although it is very close to a capital structure notification. Upon reviewing the definitions, none perfectly capture 'Total Voting Rights Disclosure'. Since it is a formal regulatory disclosure required by law, RNS is the safest classification, although it is a very specific type of filing. Let's re-evaluate: It is a mandatory disclosure about the capital structure components (shares and votes). This is often grouped with other routine compliance filings. RNS is the best fit among the provided options for a mandatory, non-financial summary regulatory notice.
2022-03-03 French
EUROPLASMA: Tirage de 2 tranches de 100 obligations convertibles en actions, d'un montant nominal total de 2 millions d'euros
Capital/Financing Update Classification · 99% confidence The document is a press release ("Communiqué de presse") dated February 25, 2021, announcing the drawing down of two tranches of convertible bonds (OCA) totaling 2 million euros under a pre-existing financing program with Global Corporate Finance Opportunities 11. This announcement details the use of funds (investments in production sites) and reminds readers of the legal framework (shareholder authorization, previous agreements). This clearly relates to the company's fundraising, financing activities, and capital structure changes. Therefore, the most appropriate classification is Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it pertains to a specific financing event.
2022-02-25 French
EUROPLASMA: Information relative au nombre total de droits de vote et d'actions composant le capital au 31 janvier 2022
Share Issue/Capital Change Classification · 95% confidence The document is a press release dated February 3, 2022, titled "Information relative au nombre total de droits de vote et d'actions composant le capital au 31 janvier 2022" (Information relative to the total number of voting rights and shares comprising the capital as of January 31, 2022). It explicitly states the total number of shares and voting rights as required by French commercial code (L. 233-8 II) and AMF regulations (223-16). This type of periodic disclosure regarding the total share capital and voting rights is a standard regulatory filing, but it specifically relates to the structure of the capital and voting power, which is often captured under general regulatory announcements or specific capital structure updates. Given the options, this is a mandatory disclosure about the capital structure. It is not an earnings release (ER), an interim report (IR), or a major shareholding notification (MRQ) which focuses on ownership changes crossing thresholds. It is a formal declaration of the capital structure as of a specific date. This fits best under general Regulatory Filings (RNS) as a mandatory disclosure, or potentially Share Issue/Capital Change (SHA) if interpreted broadly, but RNS is the most appropriate fallback for mandatory, non-financial periodic disclosures that don't fit elsewhere. However, since it is a direct declaration of the total number of shares and voting rights, which is a key component of capital structure reporting, and given the specific nature of the data provided (total shares/votes), it is a specific type of regulatory update. Since there isn't a specific code for 'Total Voting Rights Disclosure', RNS (Regulatory Filings) is the most suitable general category for mandatory regulatory updates that aren't financial reports or management changes. The document length (2805 chars) is short, but it is the primary content, not an announcement of another document.
2022-02-03 French
EUROPLASMA: Première mondiale en Chine : Succès de l'application plasma pour la valorisation des déchets dangereux d'aluminium
Regulatory Filings Classification · 90% confidence The document is titled "Communiqué de presse" (Press Release) dated January 31, 2022, announcing a technical success regarding the plasma treatment of hazardous aluminum waste in China. It details R&D results, partnership achievements, and future commercial prospects, including a reference to a previously signed Letter of Intent (LOI). This format—a news announcement highlighting recent operational or technical achievements, often leading up to a larger financial report—is characteristic of an Earnings Release (ER) or a general regulatory announcement. Since it is a press release announcing operational progress and market developments rather than a formal, comprehensive financial statement (like 10-K or IR), and it is not a transcript (CT) or a specific shareholder/director action, it fits best as an Earnings Release (ER) if it accompanies periodic results, or a general Regulatory Filing (RNS) if it's purely operational news. Given the context of reporting on a major technical milestone that opens the door for future revenue streams, it functions as a key operational update often bundled with or preceding formal earnings. However, since it is a press release announcing operational success and market progress, and not explicitly tied to a quarterly/annual earnings period summary, the most appropriate general category for a significant, non-standard operational announcement that is not a formal report is Regulatory Filing (RNS), or potentially ER if it's an unscheduled update. Given the content is a press release detailing a major technical/commercial development, and it is not a formal report itself, RNS is the safest fallback for a significant, non-standard announcement. If it were explicitly titled 'Q4 Results Press Release', ER would be better. As a general press release about a major development, RNS is appropriate, though ER is also plausible if this is the company's primary method of communicating operational highlights outside of formal filings. I will lean towards RNS as the general regulatory announcement category for significant press releases that don't fit the specific financial report codes.
2022-01-31 French
EUROPLASMA: Tirage de deux tranches de 100 obligations convertibles en actions
Capital/Financing Update Classification · 98% confidence The document is a press release dated January 27, 2022, announcing the drawing down of two tranches of convertible bonds (OCABSA) for a total nominal amount of 2 M€. This action relates directly to a financing program previously established. The content focuses on capital structure changes, debt instruments (convertible bonds), and the allocation of funds for investment projects. This clearly falls under the category of updates on company fundraising, financing activities, or capital structure changes, which corresponds to the 'Capital/Financing Update' definition. Filing Code Mapping: - AGM-R: No (Not AGM material). - 10-K: No (Not an Annual Report). - ER: No (This is a financing event, not an earnings release). - CAP: Yes. The core subject is the drawing down of convertible bonds under a financing program, which is a capital/financing activity.
2022-01-27 French
EUROPLASMA: Succès de la campagne 2021 d'Inertam et anticipation de la phase de maintenance programmée
Earnings Release Classification · 98% confidence The document is a press release ("Communiqué de presse") dated January 11, 2022, announcing the successful performance of the subsidiary Inertam for the year 2021. It provides key, unaudited financial highlights (estimated revenue of 7.6 M€, volume treated, stock reduction) and operational updates. This format, focusing on preliminary results and key performance indicators for a period (2021), strongly aligns with an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). It is not a comprehensive report (like 10-K or IR), nor is it a transcript (CT) or a formal regulatory filing announcing another report (RPA/RNS). FY 2021
2022-01-11 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.